Clinical Trial Update: CorEvitas Systemic Lupus Erythematosus (SLE) Drug Safety and Effectiveness Registry

View source ↗

Summary

CorEvitas is conducting a systemic lupus erythematosus drug safety and effectiveness registry. The study is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Systemic Lupus Erythematosus

Snippet

Sponsor: CorEvitas | Conditions: Systemic Lupus Erythematosus | Status: RECRUITING